• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性炎症反应指数、中性粒细胞与淋巴细胞比值、淋巴细胞与单核细胞比值及血小板与淋巴细胞比值对下咽鳞癌患者预后的预测价值。

The Prognostic Capacity of Systemic Inflammation Response Index, Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Hypopharyngeal Squamous Cell Carcinoma.

机构信息

Department of Radiation Oncology, Eye, Ear, Nose, and Throat Hospital of Fudan University, Shanghai, China.

Department of Otorhinolaryngology, Eye, Ear, Nose, and Throat Hospital of Fudan University, Shanghai, China.

出版信息

ORL J Otorhinolaryngol Relat Spec. 2022;84(6):453-463. doi: 10.1159/000524870. Epub 2022 Jun 16.

DOI:10.1159/000524870
PMID:35709701
Abstract

INTRODUCTION

Systemic inflammation response index (SIRI), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) have been proposed as peripheral blood biomarkers. We compared these blood biomarkers to identify the best predictor in patients with hypopharyngeal squamous cell carcinoma (HPSCC).

METHODS

We conducted a retrospective study on 304 patients with HPSCC. SIRI was divided into three groups using X-tile version 3.6.1. The optimal cut-off points for NLR, LMR, and PLR were selected through RStudio. We compared the prognostic capacity of SIRI with that of NLR, LMR, and PLR using receiver operating characteristic curves.

RESULTS

Smoking, cancer in the postcricoid region, lymph node metastasis (N+), extracapsular invasion, SIRI in the highest tertile (>2.80), and LMR in the lowest tertile (<5.0) may cause poor 5-year overall survival (OS) in patients with HPSCC. Local and distant recurrences may occur earlier in those with lymph node metastasis and a tumor invading beyond the mucosa layer.

CONCLUSIONS

SIRI was a better predictor of OS than LMR, PLR, and NLR in HPSCC patients. SIRI in the highest tertile (>2.80) and LMR in the lowest tertile (<5.0) may cause poor 5-year OS.

摘要

简介

全身性炎症反应指数(SIRI)、中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)已被提出作为外周血生物标志物。我们比较了这些血液生物标志物,以确定下咽鳞状细胞癌(HPSCC)患者中最佳的预测指标。

方法

我们对 304 例 HPSCC 患者进行了回顾性研究。使用 X-tile 版本 3.6.1 将 SIRI 分为三组。通过 RStudio 选择 NLR、LMR 和 PLR 的最佳截断值。我们通过接受者操作特征曲线比较 SIRI 与 NLR、LMR 和 PLR 的预后能力。

结果

吸烟、后区癌症、淋巴结转移(N+)、包膜外侵犯、SIRI 最高三分位(>2.80)和 LMR 最低三分位(<5.0)可能导致 HPSCC 患者 5 年总生存率(OS)较差。有淋巴结转移和肿瘤侵犯黏膜层以外的患者可能更早出现局部和远处复发。

结论

SIRI 是 HPSCC 患者 OS 的更好预测指标,优于 LMR、PLR 和 NLR。SIRI 最高三分位(>2.80)和 LMR 最低三分位(<5.0)可能导致 5 年 OS 较差。

相似文献

1
The Prognostic Capacity of Systemic Inflammation Response Index, Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in Patients with Hypopharyngeal Squamous Cell Carcinoma.系统性炎症反应指数、中性粒细胞与淋巴细胞比值、淋巴细胞与单核细胞比值及血小板与淋巴细胞比值对下咽鳞癌患者预后的预测价值。
ORL J Otorhinolaryngol Relat Spec. 2022;84(6):453-463. doi: 10.1159/000524870. Epub 2022 Jun 16.
2
Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.术前外周血 NLR、PLR、LMR 与头颈部鳞状细胞癌患者预后的相关性。
BMC Cancer. 2023 Dec 18;23(1):1247. doi: 10.1186/s12885-023-11752-y.
3
Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.头颈部鳞状细胞癌的全身免疫反应:一致性指数分析比较。
Eur Arch Otorhinolaryngol. 2019 Oct;276(10):2913-2922. doi: 10.1007/s00405-019-05554-x. Epub 2019 Jul 16.
4
The Association of the Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Systemic Inflammation Response Index with Short-Term Functional Outcome in Patients with Acute Ischemic Stroke.急性缺血性脑卒中患者中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、淋巴细胞与单核细胞比值及全身炎症反应指数与短期功能预后的相关性
J Inflamm Res. 2023 Aug 23;16:3619-3630. doi: 10.2147/JIR.S418106. eCollection 2023.
5
The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.预处理全身炎症反应指数作为一个有用的预后因素优于淋巴细胞与单核细胞比值在接受新辅助化疗的乳腺癌患者。
Clin Breast Cancer. 2022 Jul;22(5):424-438. doi: 10.1016/j.clbc.2022.03.003. Epub 2022 Mar 21.
6
Blood Markers Predicting Clinically Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.血液标志物预测头颈部鳞状细胞癌隐匿性淋巴结转移。
ORL J Otorhinolaryngol Relat Spec. 2024;86(1):32-40. doi: 10.1159/000534079. Epub 2023 Nov 16.
7
In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.在接受新辅助化疗的胃癌患者中,全身炎症反应指数是一种有用的预后指标。
Pathol Oncol Res. 2021 Oct 12;27:1609811. doi: 10.3389/pore.2021.1609811. eCollection 2021.
8
Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.中性粒细胞与淋巴细胞比值和单核细胞与嗜酸性粒细胞比值作为晚期鼻咽癌的预后指标。
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):1971-1989. doi: 10.1007/s00405-024-08474-7. Epub 2024 Feb 5.
9
The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation.放疗/同步放化疗治疗喉癌/下咽癌患者时,治疗前外周血淋巴细胞、单核细胞及中性粒细胞比例的临床影响
Cancer Manag Res. 2020 Sep 25;12:9013-9021. doi: 10.2147/CMAR.S275635. eCollection 2020.
10
Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.完整血球计数评分模型整合了降低的淋巴细胞单核细胞比值、升高的中性粒细胞淋巴细胞比值和升高的血小板淋巴细胞比值,可预测成人 T 淋巴细胞白血病不良的临床结局。
Oncologist. 2019 Nov;24(11):e1123-e1131. doi: 10.1634/theoncologist.2018-0789. Epub 2019 Apr 5.

引用本文的文献

1
An integrated machine learning-based prognostic model in head and neck cancer using the systemic inflammatory response index and correlations with patient reported financial toxicity.一种基于机器学习的头颈癌综合预后模型,使用全身炎症反应指数以及与患者报告的经济毒性的相关性。
Res Sq. 2025 May 7:rs.3.rs-6529613. doi: 10.21203/rs.3.rs-6529613/v1.